The journey from one Paralympics to another isn't easy. That was especially true from Tokyo to Paris, with an atypical three-year gap between Games due to the COVID-19 pandemic pushing back the former ...
If you are following Adaptive Biotechnologies (ADPT), the news that its collaboration and license agreement with Genentech is ending might catch your eye. The two biotech firms will wind down their ...
The public market is bullish on Adaptive Biotechnologies. The biotech company started trading on the Nasdaq exchange under the symbol ADPT at $38 per share Thursday morning, up 90 percent from the $20 ...
Adaptive will be the sole tenant at 1165 Eastlake Ave. in Seattle’s Lake Union neighborhood. (Alexandria Real Estate Equities Photo) Adaptive Biotechnologies is charting a massive expansion of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results